90 related articles for article (PubMed ID: 21411738)
1. CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphoma.
Burington B; Yue P; Shi X; Advani R; Lau JT; Tan J; Stinson S; Stinson J; Januario T; de Vos S; Ansell S; Forero-Torres A; Fedorowicz G; Yang TT; Elkins K; Du C; Mohan S; Yu N; Modrusan Z; Seshagiri S; Yu SF; Pandita A; Koeppen H; French D; Polson AG; Offringa R; Whiting N; Ebens A; Dornan D
Sci Transl Med; 2011 Mar; 3(74):74ra22. PubMed ID: 21411738
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of extracellular signal-regulated kinase predisposes diffuse large B-cell lymphoma cell lines to CD40-mediated cell death.
Hollmann CA; Owens T; Nalbantoglu J; Hudson TJ; Sladek R
Cancer Res; 2006 Apr; 66(7):3550-7. PubMed ID: 16585179
[TBL] [Abstract][Full Text] [Related]
3. Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40.
Law CL; Gordon KA; Collier J; Klussman K; McEarchern JA; Cerveny CG; Mixan BJ; Lee WP; Lin Z; Valdez P; Wahl AF; Grewal IS
Cancer Res; 2005 Sep; 65(18):8331-8. PubMed ID: 16166310
[TBL] [Abstract][Full Text] [Related]
4. Dacetuzumab, a humanized mAb against CD40 for the treatment of hematological malignancies.
Khubchandani S; Czuczman MS; Hernandez-Ilizaliturri FJ
Curr Opin Investig Drugs; 2009 Jun; 10(6):579-87. PubMed ID: 19513947
[TBL] [Abstract][Full Text] [Related]
5. Vav-1 expression correlates with NFκB activation and CD40-mediated cell death in diffuse large B-cell lymphoma cell lines.
Hollmann A; Aloyz R; Baker K; Dirnhofer S; Owens T; Sladek R; Tzankov A
Hematol Oncol; 2010 Sep; 28(3):142-50. PubMed ID: 20155735
[TBL] [Abstract][Full Text] [Related]
6. Regulatory roles of N-glycosylation of immunoglobulin M in CD40-CD40L-mediated cell survival of human diffuse large B cell lymphoma.
Suzuki O; Nozawa Y; Abe M
Oncol Rep; 2004 May; 11(5):1031-9. PubMed ID: 15069543
[TBL] [Abstract][Full Text] [Related]
7. CD40 expression by human melanocytic lesions and melanoma cell lines and direct CD40 targeting with the therapeutic anti-CD40 antibody CP-870,893.
Kalbasi A; Fonsatti E; Natali PG; Altomonte M; Bertocci E; Cutaia O; Calabrò L; Chiou M; Tap W; Chmielowski B; Maio M; Ribas A
J Immunother; 2010 Oct; 33(8):810-6. PubMed ID: 20842056
[TBL] [Abstract][Full Text] [Related]
8. Mature B cells are critical to T-cell-mediated tumor immunity induced by an agonist anti-GITR monoclonal antibody.
Zhou P; Qiu J; L'Italien L; Gu D; Hodges D; Chao CC; Schebye XM
J Immunother; 2010 Oct; 33(8):789-97. PubMed ID: 20842058
[TBL] [Abstract][Full Text] [Related]
9. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
Walker A; Taylor ST; Hickman JA; Dive C
Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional repressor BCL-6 immortalizes germinal center-like B cells in the absence of p53 function.
Kusam S; Vasanwala FH; Dent AL
Oncogene; 2004 Jan; 23(3):839-44. PubMed ID: 14737119
[TBL] [Abstract][Full Text] [Related]
11. Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression.
Durandy A; Hivroz C; Mazerolles F; Schiff C; Bernard F; Jouanguy E; Revy P; DiSanto JP; Gauchat JF; Bonnefoy JY; Casanova JL; Fischer A
J Immunol; 1997 Mar; 158(6):2576-84. PubMed ID: 9058789
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with immature dendritic cells combined with CD40mAb induces protective immunity against B lymphoma in hu-SCID mice.
Ge Y; Xi H; Zhang XG
Biomed Pharmacother; 2010 Sep; 64(7):487-92. PubMed ID: 20382498
[TBL] [Abstract][Full Text] [Related]
13. Activation of mitogen-activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells.
Kashiwada M; Kaneko Y; Yagita H; Okumura K; Takemori T
Eur J Immunol; 1996 Jul; 26(7):1451-8. PubMed ID: 8766546
[TBL] [Abstract][Full Text] [Related]
14. Tumor regression by anti-CD40 and interleukin-2: role of CD40 in hematopoietic cells and organ-specific effects.
Welniak LA; Shorts L; Subleski J; Blazar BR; Wiltrout RH; Murphy WJ
Biol Blood Marrow Transplant; 2004 Aug; 10(8):534-9. PubMed ID: 15282531
[TBL] [Abstract][Full Text] [Related]
15. CD40 ligand exerts differential effects on the expression of I gamma transcripts in subclones of an IgM+ human B cell lymphoma line.
Ford GS; Yin CH; Barnhart B; Sztam K; Covey LR
J Immunol; 1998 Jan; 160(2):595-605. PubMed ID: 9551893
[TBL] [Abstract][Full Text] [Related]
16. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
[TBL] [Abstract][Full Text] [Related]
17. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
Dranitzki-Elhalel M; Huang JH; Sasson M; Rachmilewitz J; Parnas M; Tykocinski ML
Int Immunol; 2007 Apr; 19(4):355-63. PubMed ID: 17314083
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide inhibition of anti-CD40 monoclonal antibody-based therapy of B cell lymphoma is dependent on CD11b+ cells.
Honeychurch J; Glennie MJ; Illidge TM
Cancer Res; 2005 Aug; 65(16):7493-501. PubMed ID: 16103104
[TBL] [Abstract][Full Text] [Related]
19. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.
Hsing Y; Hostager BS; Bishop GA
J Immunol; 1997 Nov; 159(10):4898-906. PubMed ID: 9366415
[TBL] [Abstract][Full Text] [Related]
20. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S
Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
